Skip to content

Chelation Therapy Trials & Studies

Many EDTA Chelation studies have been concluded and people ask why have I never heard of Chelation therapy, well here are just a few of them that offer various outcomes.

associated words group showing edta chelation studies and treatment summaryClinical Studies and Documentation – EDTA Chelation

The TACT 1&2 Trials concluded in 2012 in the United States and Canada at 86 locations. The purpose of the study was to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in people with coronary artery disease.

Please note that these trials were performed with the IV delivery method and not by oral.

You can read the results and draw your own conclusions at the official website https://clinicaltrials.gov/study/NCT00044213?tab=results

Much controversy surrounds the TACT trials for positives and negatives so you should form your own opinion https://jamanetwork.com/journals/jama/fullarticle/1672219

Collaborators and Investigators
The is people and organisations involved with this study.

Sponsor
Mt. Sinai Medical Center, Miami
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
National Center for Complementary and Integrative Health (NCCIH)
Investigators
Study Director: Gervasio A Lamas, M.D.,Icahn School of Medicine at Mount Sinai

The Food and Drug Administration (FDA) has approved the synthetic amino acid, ethylene diamine tetra acetic acid (EDTA), as a pharmaceutical agent for the treatment of lead and other heavy metal poisoning and specific mineral overloads.

In older literature, EDTA was also approved for intravenous treatment as possibly effective in vascular disorders, arrhythmias, atrioventricular induction  defects and in the treatment where calcium tissue deposits or hypercalcemia may contribute other than those listed.

However these possibly effective indications were removed from FDA approved literature in the late 1970’s for reasons known only to the FDA. No explanation was given.

Fortunately, Doctors and alternative practitioners are not limited solely to approved procedures and may prescribe for whatever conditions they find to be effective.

Consequently, since Chelation is approved for the treatment of heavy metal poisoning (especially lead), many doctors, clinics and private practitioners continue to use Chelation Therapy with great benefit in many diseases and conditions other than their officially approved uses.

Following the same path as the United States. In the UK, the National Health Service (NHS) and official health bodies approve chelation therapy for specific medical conditions such as heavy metal poisoning and iron overload.

Official NHS Uses for Chelation

  • Iron Overload: Used for conditions such as thalassaemia, sickle cell disease, or haemochromatosis when regular blood removal is unsafe or not possible. [1, 2, 3]
    Metal Poisoning: Managed via the UK National Poisons Information Service (NPIS) for severe lead, mercury, or other acute toxic exposures. [1, 2]

Unofficial and Alternative Uses for Chelation.

  • Heart Disease and Autism: Official UK bodies do not recommend or endorse IV chelation therapy for treating heart disease, atherosclerosis, or autism.
  • Private Clinics: Some private clinics offer intravenous “heavy metal detox” packages, however these lack backing from mainstream medicine.

Alternative Treatments for Chelation.

Specialised training organisations exist to certify Doctors and Practitioners. Based in the US these are;

The American College for Advancement in Medicine (ACAM)

Being a non profit medical organisation ACAM educates healthcare professionals about integrative, preventive, and nutritional medicine

Founded in 1973 ACAM is the most prominent medical organisation that is dedicated to training physicians in EDTA chelation therapy for cardiovascular and atherosclerotic diseases. Website: https://www.acam.org/

The American Academy of Anti-Aging Medicine (A4M)

A4M is a professional association concentrating on preventative, functional, and integrative medicine.

Through its advanced clinical training, A4M provides practical instructions for physicians on evaluating heavy metal toxicity and intravenous chelation therapy to manage the oxidative stress of atherosclerosis and cardiovascular aging.
Website: https://www.a4m.com/

The International College of Integrative Medicine (ICIM)

ICIM is a body of health professionals and physicians dedicated to advanced evidence based integrative therapies.

The organisation hosts training sessions, certified courses and reviews on innovative cardiovascular therapies, including the specific administration of intravenous EDTA chelation.
Website: https://www.icimed.com/

Members of these organisations and their patients find that chelation therapy is highly effective as an alternative or addition to more traditional and widely accepted approaches such as angioplasty or bypass surgery.

EDTA Has Multiple uses as a food additive

In addition to its remarkable pharmaceutical uses, Ethylene-diaminetetraacetic-acid is also approved as a food additive that is generally recognized as safe (GRAS).

It’s array of biochemical properties make it extremely valuable as a food additive.

It has the ability to: (1) bind with many metals; (2) act synergistically with other antioxidants to stabilize fats and oils; (3) prevent discoloration of potato products; (4) stabilize vitamins; (5) prevent discoloration of fish and shellfish; (6) prevent flavor changes in milk; (7) inhibit the thickening of stored condensed milk; (8) enhance the foaming properties of reconstituted skim milk; (9) prevent color changes of scrambled eggs prepared from egg powder; (10) preserve canned legumes; (11) prevent gushing in beer; (12) promote flavor retention and delay loss of carbonation in soft drinks; (13) prevent oxidation of meat products; and (14) prevent discoloration of canned fruits and vegetables.

Those unable to obtain intravenous chelation therapy due to financial, occupational, geographical or other restraints, or who wish to undergo a less intensive approach may be able to obtain many of the benefits of intravenous chelation therapy by consuming Oral EDTA (Ethylene-diamine-tetraacetic acid).